Search | Virtual Health Library

1.

Activated CD4+ T cells target mesangial antigens and initiate glomerulonephritis.

Scindia, Yogesh; Nackiewicz, Dominika; Dey, Paromita; Szymula, Agnieszka; Bajwa, Amandeep; Rosin, Diane L; Bolton, W Kline; Okusa, Mark D; Deshmukh, Umesh; Bagavant, Harini.

Nephron Exp Nephrol ; 121(1-2): e1-9, 2012.

Article in English | MEDLINE | ID: mdl-23095207

2.

Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients.

Fishbane, Steven; Bolton, W Kline; Winkelmayer, Wolfgang C; Strauss, William; Li, Zhu; Pereira, Brian J G.

Clin Nephrol ; 78(3): 181-8, 2012 Sep.

Article in English | MEDLINE | ID: mdl-22874106

3.

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.

Awad, Alaa S; Kinsey, Gilbert R; Khutsishvili, Konstantine; Gao, Ting; Bolton, W Kline; Okusa, Mark D.

Am J Physiol Renal Physiol ; 301(6): F1358-66, 2011 Dec.

Article in English | MEDLINE | ID: mdl-21880831

4.

Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.

Awad, Alaa S; Rouse, Michael D; Khutsishvili, Konstantine; Huang, Liping; Bolton, W Kline; Lynch, Kevin R; Okusa, Mark D.

Kidney Int ; 79(10): 1090-8, 2011 May.

Article in English | MEDLINE | ID: mdl-21289599

5.

Vascular access for HD: aligning payment with quality.

Amedia, Chester A; Bolton, W Kline; Cordray, Trelles; Hakim, Ray; Howard, Randy; Jackson, Jerry; Kulawik, Deuzimar; Lyon, Maryam; Mahoney, David; Messana, Anthony; Nissenson, Allen; Oviatt, Lauren; Parlato, David; Roddy, Sean; Solid, Craig.

Semin Dial ; 24(1): 37-40, 2011.

Article in English | MEDLINE | ID: mdl-21338392

6.

The mortality risk associated with higher hemoglobin: is the therapy to blame?

Rosner, Mitchell H; Bolton, W Kline.

Kidney Int ; 74(6): 695-7, 2008 Sep.

Article in English | MEDLINE | ID: mdl-18756292

7.

The normal HCT trial re-revisited: what were the actual findings?

Besarab, Anatole; Bolton, W Kline; Nissenson, Allen R; Schwab, Steven J.

Kidney Int ; 82(2): 242; author reply 242-3, 2012 Jul.

Article in English | MEDLINE | ID: mdl-22743566

8.

Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.

Williams, Mark E; Bolton, W Kline; Khalifah, Raja G; Degenhardt, Thorsten P; Schotzinger, Robert J; McGill, Janet B.

Am J Nephrol ; 27(6): 605-14, 2007.

Article in English | MEDLINE | ID: mdl-17823506

9.

Molecular mapping of the Goodpasture's epitope for glomerulonephritis.

Bolton, W Kline; Chen, Lanlin; Hellmark, Thomas; Fox, Jay; Wieslander, Jorgen.

Trans Am Clin Climatol Assoc ; 116: 229-36; discussion 237-8, 2005.

Article in English | MEDLINE | ID: mdl-16555617

10.

Pimagedine: a novel therapy for diabetic nephropathy.

Abdel-Rahman, Emaad; Bolton, W Kline.

Expert Opin Investig Drugs ; 11(4): 565-74, 2002 Apr.

Article in English | MEDLINE | ID: mdl-11922864

11.

The prevalence of anemia in patients with chronic kidney disease.

McClellan, William; Aronoff, Stephen L; Bolton, W Kline; Hood, Sally; Lorber, Daniel L; Tang, K Linda; Tse, Thomas F; Wasserman, Brian; Leiserowitz, Marc.

Curr Med Res Opin ; 20(9): 1501-10, 2004 Sep.

Article in English | MEDLINE | ID: mdl-15383200

12.

Seasons.

Bolton, W Kline.

Nephron Physiol ; 112(1): p24-6, 2009.

Article in English | MEDLINE | ID: mdl-19451727

13.

Preparing the patient for renal replacement therapy. Teamwork optimizes outcomes.

Bolton, W Kline; Owen, William F.

Postgrad Med ; 111(6): 97-8, 101-4, 107-8, 2002 Jun.

Article in English | MEDLINE | ID: mdl-12082923

14.

Comanagement of diabetic kidney disease by the primary care provider and nephrologist.

Bowman, Brendan T; Kleiner, Amanda; Bolton, W Kline.

Med Clin North Am ; 97(1): 157-73, 2013 Jan.

Article in English | MEDLINE | ID: mdl-23290736

15.

What sensitized cells just might be doing in glomerulonephritis.

Bolton, W Kline.

J Clin Invest ; 109(6): 713-4, 2002 Mar.

Article in English | MEDLINE | ID: mdl-11901177

16.

Renal function testing.

Rosner, Mitchell H; Bolton, W Kline.

Am J Kidney Dis ; 47(1): 174-83, 2006 Jan.

Article in English | MEDLINE | ID: mdl-16377400

17.

Pulmonary renal syndrome and emergency therapy.

Bolton, W Kline.

Contrib Nephrol ; 165: 166-173, 2010.

Article in English | MEDLINE | ID: mdl-20427967

18.

Ferumoxytol for the treatment of anemia in chronic kidney disease.

Rosner, Mitchell H; Bolton, W Kline.

Drugs Today (Barc) ; 45(11): 779-86, 2009 Nov.

Article in English | MEDLINE | ID: mdl-20126670

19.

Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.

Khan, Sana; Bolton, W Kline.

Clin J Am Soc Nephrol ; 9(6): 1001-4, 2014 Jun 06.

Article in English | MEDLINE | ID: mdl-24855281

20.

A good reason to measure 24-hour urine creatinine excretion, but not to assess kidney function.

Kalantari, Kambiz; Bolton, W Kline.

Clin J Am Soc Nephrol ; 8(11): 1847-9, 2013 Nov.

Article in English | MEDLINE | ID: mdl-24158794

Virtual Health Library

Hypertension

Your selection (0)

Export format:

Export:

Activated CD4+ T cells target mesangial antigens and initiate glomerulonephritis.

Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients.

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.

Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.

Vascular access for HD: aligning payment with quality.

The mortality risk associated with higher hemoglobin: is the therapy to blame?

The normal HCT trial re-revisited: what were the actual findings?

Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.

Molecular mapping of the Goodpasture's epitope for glomerulonephritis.

Pimagedine: a novel therapy for diabetic nephropathy.

The prevalence of anemia in patients with chronic kidney disease.

Seasons.

Preparing the patient for renal replacement therapy. Teamwork optimizes outcomes.

Comanagement of diabetic kidney disease by the primary care provider and nephrologist.

What sensitized cells just might be doing in glomerulonephritis.

Renal function testing.

Pulmonary renal syndrome and emergency therapy.

Ferumoxytol for the treatment of anemia in chronic kidney disease.

Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.

A good reason to measure 24-hour urine creatinine excretion, but not to assess kidney function.